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Enterovirus 71 (EV71) is a common cause of hand, foot and mouth disease (HFMD) a 
disease endemic especially in the Asia-Pacific region1. Scavenger receptor class B 
member 2 (SCARB2) is the major receptor of EV71, and several other enteroviruses 
responsible for HFMD, and plays a key role in cell entry2. Although the structures of 
EV71 and SCARB2 are known3-6 we do not know how they interact to initiate infection. 
We report here the EV71-SCARB2 complex structure determined at 3.4 Å resolution 
using cryo-electron microscopy (cryoEM). This reveals that SCARB2 binds EV71 on 
the southern rim of the canyon, rather than across the canyon as was expected. Helices 
152-163 and 183-193 of SCARB2 and the VP1 GH and VP2 EF loops of EV71 dominate 
the interaction, suggesting a plausible mechanism by which receptor binding might 
facilitate the low pH uncoating of the virus in the endo/lysosome. Remarkably, many 
residues within the binding footprint are not conserved across SCARB2 dependent 
enteroviruses, however a conserved proline and glycine seem key residues. Thus, 
although the virus maintains antigenic variability even within the receptor binding 
footpULQWWKHLGHQWLILFDWLRQRIELQGLQJµKRWVSRWV¶PD\IDFLOLWDWHWKHGHVLJQRIUHFHSWRU
mimic therapeutics less likely to quickly generate resistance.  
 
 
HFMD is a viral disease that infects mainly infants and children and has caused repeated 
epidemics in the Asia-Pacific region for more than 20 years7, with around 2,000,000 cases 
every year since 2010. Whilst Coxsackievirus A16 (CV-A16) and EV71 are major etiological 
agents of HFMD, a variety of viruses in the genus Enterovirus, including many other type A 
and some type B enteroviruses also cause the disease1. HFMD usually leads to relatively mild 
symptoms, such as fever, oral ulcerations, and swellings on the hands and feet. However, 
EV71 infection is sometimes associated with cardiac and central nervous system 
complications and even death8. Enteroviruses belong to the picornavirus family of 
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icosahedral, unenveloped viruses9. They contain a positive sense single-stranded RNA 
genome which when released into the cytoplasm initiates infection, being directly translated 
by host ribosomes. This initial stages of infection involves attachment to a host cell protein 
receptor, internalisation, uncoating (which for enteroviruses is presumed to occur via 
expansion of the particle following ejection of a lipid pocket factor from the VP1 E-barrel 
resulting in a cascade of structural rearrangements10) and release of the genome through a 
membrane pore into the cytoplasm11. Correct engagement with a specific receptor is therefore 
critical to infectivity and can control virus tropism at both species and tissue level12. This 
makes receptor-virus interactions attractive targets for ant-viral therapeutics, since it may be 
more difficult for a virus to acquire resistance to such a compound than to a classic enzyme 
inhibitor. Recently, a number of receptors have been identified for many of the etiological 
agents of HFMDV, notable receptors include SCARB2 (a receptor for EV71, CV-A16 and a 
sub-group of type A enteroviruses)2, Kremin1 for CV-A1013, PSGL1 for EV71 and CAR and 
DAF for Group B enteroviruses14. The usage of receptors correlates with the capsid structure 
indicating that receptor switching drives evolution (Fig. 1a). Unfortunately to date there are 
no high resolution data available on receptor/HFDV complexes. It has however been inferred 
that SCARB2 binds at the so-called canyon, a depression that in enteroviruses encircles the 
icosahedral 5-fold axes and harbours the binding sites for slender immunoglobulin-domain 
based receptors 15, although SCARB2 is a much bulkier molecule.  
 
SCARB2, also known as LIMP-2, is a type III membrane protein with N- and C-terminal 
transmembrane helices16. It is found especially in lysosomal limiting membranes and its 400 
residue luminal domain is heavily glycosylated with nine potential N-linked glycosylation 
sites6. SCARB2 has a major role in endo/lysosomal membrane organization, with mutations 
causing several neurodegenerative and renal diseases. There is good evidence that attachment 
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to SCARB2 mediates internalisation and uncoating in EV71, and is required for the latter 
stages17,18. It has, however, been established that uncoating requires not only attachment to 
SCARB2, but also low pH. This implies that binding to SCARB2 might destabilise the virus 
particle at low pH (leading to the formation of expanded or µA-particles¶5,10). Our aim was to 
visualise the initial attachment complex and so we used a variant of EV71 genotype B2 
whose infectivity is enhanced at low pH by a single mutation VP1 N104S (Methods). The 
particles were further stabilised by replacing the natural pocket factor by a potent expansion-
inhibitor, NLD (Methods). Using these stabilised particles, we determined the structure of the 
luminal domain of SCARB2 in complex with EV71 at a pH of 5.1 by cryoEM (see Methods 
and Extended Data Fig. 1a:HILQGXQH[SHFWHGO\WKDW6&$5%ELQGVWRWKHµVRXWKHUQULP¶
of the canyon, interacting with loops from two of the major capsid proteins, VP2 and VP1 
(Fig. 1b). The structure is at sufficient resolution for us to build and refine an atomic model 
of the complex (Fig. 1c,d, Methods and Extended Data Table 1). The virus structure is in the 
un-expanded state with NLD remaining bound in the VP1 pocket (Fig. 1c) and the virus 
capsid is essentially indistinguishable from the native mature virus (the RMSD for 774 
matched CĮs, out of a total of 784 is 0.4 Å). Interaction of the receptor with the virus is 
through helices Į5 and Į7, which together with Į form a bundle lying distal from the 
domain termini, and therefore from the membrane (Fig. 2a)6. This is consistent with previous 
observations that the C-terminal end of Į4 is directly involved in attachment and the 
observation that Į5 forms part of the epitope of an Fab which binds SCARB2 to prevent virus 
attachment19. It has been noted that this helical bundle undergoes pH dependent 
conformational changes, and it has been proposed that these changes are involved in a pH 
dependent triggering of viral uncoating3,6.  Interestingly, although our structural analysis was 
performed at relatively low pH (5.1) the structure of the helical bundle is essentially 
indistinguishable from that observed for the isolated protein at neutral pH3,4,6 (Fig. 2b), 
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consistent with our strategy of locking the virus in a pre-uncoating state by using a mutant 
virus adapted to low pH and replacing the lipid pocket factor with the tighter binding NLD 
molecule (Methods). Whilst much of the surface of the luminal domain of SCARB2 is 
shielded by nine complex glycans the EV71 binding site is largely clear of glycosylation 
sites, although a long well-ordered phosphorylated sugar has been seen to approach this 
region of the SCARB2 surface6 (Fig. 2a). Considering that it is highly exposed in the apo 
structure the binding site is surprisingly hydrophobic, suggesting that this region is involved 
in protein-protein interactions as part of its function in the host. Indeed it has been proposed 
WKDWLW¶VSDUWQHUȕ-Glucosidase uses this region as part of its attachment site6 (Extended Data 
Fig. 2c). In addition to hydrophobic interactions there are limited hydrogen bond and charge 
interactions which will be described below from the perspective of the virus. Overall the 
footprint of the receptor on the virus is ~700 Å2, similar to that observed for tightly binding 
antibodies. 
 
The SCARB2 binding site on EV71 is composed of residues from the VP2 EF and the VP1 
GH loop, which form part of the south wall of the canyon and bear antigenic residues. The 
VP2 EF loop is shorter in EV71 than in most other enteroviruses (e.g. 15 residues shorter 
than for poliovirus type 1) and residues 134 to 162 from this loop, together with residues 214 
to 216 in the VP1 GH loop form a platform upon which the receptor sits (Fig. 3a). The first 
hypothesis for receptor binding to enteroviruses (the canyon hypothesis, proposed in 1985) 
was that slender receptors would insert into the canyon, thereby allowing the necessarily 
conserved attachment residues to be concealed from immune surveillance, since the rather 
blunt antibody would be unable to reach into the canyon20. In the intervening years, it has 
become clear that across picornaviruses, receptor binding can be more varied (the current 
situation is summarized in Extended Data Fig. 3), however it remains true that this mode of 
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attachment is common amongst some enteroviruses (e.g. poliovirus). Indeed, the assumption 
has been that SCARB2 binding will follow this pattern21 and so it is surprising that the 
ELQGLQJVLWHLVHVVHQWLDOO\DSODWIRUPWKDWOLHVRXWVLGHRIWKHFDQ\RQH[WHQGLQJWRWKHµVRXWK¶
(Fig. 3b). This site is roughly similar to that observed for DAF binding to echovirus-722, and 
for integrin binding to foot-and-mouth disease virus 23, so that all current receptor attachment 
sites for picornaviruses can be grouped into three areas on the virus surface (Extended Data 
Fig. 3). The SCARB2 binding residues are unremarkable, largely non-conserved and there is 
no strong surface charge characterising the region (Fig. 3c,d). The interactions are detailed in 
Extended Data Table 2. In summary, there are 14 viral and 19 receptor residues involved in 
hydrophobic interactions (ื 4.0 Å), 4 potential hydrogen bonds and 2 potential charged 
interactions. Of these, 3 of the key interactions are with the main chain of the viral 
polypeptides. A significant sub-set of the agents of HFMD use SCARB2 as a receptor (Fig. 
1a) and it is likely that the binding site is conserved across these viruses. However a 
surprisingly large number of residues in the binding site are not conserved across the known 
SCARB2 binders (10 out of 14 residues, Extended Data Fig. 4). We assume that this 
variability arises from antigenic variation, which has presumably led to the differentiation of 
the SCARB2 binding subset of enteroviruses, indeed EV71 vaccine does not provide 
protection against another SCARB2 binding virus, CV-A16. How then do these viruses 
maintain specificity for SCARB2 in the face of sequence variation? Of the SCARB2 binding 
residues VP2 Gly 137, Pro 147 and Tyr 148 are conserved. From the antigenic perspective, 
only the tyrosine presents a signature side-chain recognition signal, but the others have 
structural properties that can control local protein folding. All three residues are involved in 
key interactions with SCARB2 (Fig. 3c,d). It appears that the recognition involves a 
significant proportion of side-chain independent interactions, which may mitigate the 
constraints imposed on antigenic variation by maintenance of receptor binding. A snapshot of 
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this can be seen in an analysis of the immune response of recovered patients24, where by 
single cell sequencing, the epitopes of the key neutralising antibodies were mapped by 
identifying mutations in EV71 that abrogated neutralisation. The results are shown in Fig. 4a. 
It is striking that all except one of the mutations are outside of the SCARB2 footprint, 
scattered widely on the capsid, suggesting that neutralising responses are directed at epitopes 
that at most overlap the receptor binding site only partially. It appears that, rather akin to the 
exposed receptor binding site of foot-and-mouth disease virus23, SCARB2 binding 
enteroviruses manage to hide their receptor binding site in full view of the immune response.  
 
If the EV71/SCARB2 complex provides a counter example to the canyon hypothesis, does it 
clarify how receptor binding and low pH might trigger uncoating (for the canyon hypothesis 
receptor binding to the floor of the canyon could induce changes leading to the release of the 
pocket factor lying directly below the canyon floor). Fig. 4b shows the relative position of the 
SCARB2 attachment site, the pocket factor binding site, and the conformational changes that 
occur on transition to the expanded form of the virus and low pH form for SCARB23,4. It 
seems plausible that in wild type virus, without additional stabilisation of the pocket, 
structural changes in the SCARB2 helical bundle induced as the pH drops (late 
endo/lysosome) would exert mechanical strain on the virus capsid. Specifically we find that 
SCARB2 attaches such that the pH induced conformational change observed previously 
would act as a lever on the VP1 GH loop through movement of Į7 away from Į5, which is 
strongly anchored to the VP2 EF loop. This agrees with our previous proposal that the VP1 
GH loop, which undergoes conformational changes upon particle expansion, acts as the 
sensor in a sensor-adaptor uncoating mechanism5,10,25, and initiates a cascade of changes, 
which include the loss/expulsion of the pocket factor and expansion of the particle to 
facilitate the release of the N-terminus of VP1, VP4 and, ultimately the viral genome. In 
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agreement with this we note that mutation of one of the VP1 GH loop residues (K215A) 
increases thermostability, but produces a slow growth phenotype26. This is an attractive 
mechanism, but remains speculative pending experimental evidence. Indeed some 
experimental results remain hard to explain, for instance mutation VP1 Q172A abolished 
binding to SCARB2 in pull-downs (and a similar result was seen with mutations of 
neighbouring residues), also VP1 mutations K98E, E145A and L169F enable EV71 to 
interact with murine SCARB2 [27,28] . It is conceivable that these residues, distant from the 
SCARB2 binding site, act through subtle allosteric affects.  In summary, the complex of 
EV71 with SCARB2 reveals an unexpected mode of attachment, and suggests mechanisms of 
DQWLJHQLFFDPRXIODJHDQGUHFHSWRUS+PHGLDWHGXQFRDWLQJ.QRZOHGJHRIWKHVSHFLILFµKRW
VSRWV¶RIWKLVLQWHUDFWLRQPD\KHOSLQWKHGHVLJQRIVPDOOPROHFXOHVRUPRUHOLNHO\ELRORJLFV
that block viral entry, for instance nanobodies, being smaller than antibodies, might be able to 
target residues that cannot be altered without compromising virus viability, indeed an 
unwitting proof of principle of this has been made by Xu et al.29,30 who grafted parts of the 
VP1 GH and VP2 EF loops into a recombinant vaccine that protected mice from a lethal 
EV71 challenge. 
 
Methods 
Expression and Purification of SCARB2 
Soluble truncated SCARB2 with His-tag was expressed in HEK 293T cells, as described 
earlier6. Cells were centrifuged at 1,500g for 20min and the supernatant was dialysed in 
buffer (1.7 mM NaH2PO4, 23 mM Na2HPO4, 250 mM NaCl, pH 8.0) at 4 °C for 48h. Then 
the sample was filtered and loaded to a 5mL HisTrap Nickel column (GE Healthcare). Buffer 
(20mM Tris, 200mM NaCl, 30mM immidazole, pH 8.0) was used to wash the Nickel 
column, followed by elution with buffer (20mM Tris, 200mM NaCl, 500mM imidazole, pH 
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8.0). Then the eluate was loaded onto a Superdex 75 16/60 gel filtration column (GE 
Healthcare) for further purification. Buffer (20mM Tris, 200mM NaCl, pH 8.0) was used for 
gel filtration. Purified SCARB2 was concentrated using a 10 KDa ultrafiltration tube 
(Amicon). 
Virus Production and Purification 
Low-pH-enhanced EV71 genotype B2, which has a mutation of VP1 N104S, was used to 
infect Vero cells31. 3 days after infection, virus was harvested and 0.5% (v/v) NP40 was 
added. The sample was stored at -80°C until needed. For purification, three freeze-thaw 
cycles were done to ensure full release of virus from the cells. Then 8% (w/v) PEG 6000 was 
added to precipitate virus. The sample was centrifuged at 3,500g for 1h at 4°C, then the pellet 
was suspended in ~35ml buffer (100mM Na-acetate, 200mM NaCl, 0.5% (v/v) NP40, pH 
5.0) and centrifuged at 3,500g for 30 min at 4°C to remove cell debris. Virus particles in the 
supernatant were pelleted through a 2ml 30% (w/v) sucrose cushion (in 100mM Na-acetate, 
200mM NaCl, pH 5.0) at 105,000g for 3h at 4°C. The pellet was suspended in buffer 
(100mM Na-acetate, 200mM NaCl, 0.5% (v/v) NP40, pH 5.0) and centrifuged at 12,000g for 
30 min at 4°C to remove insoluble material. The supernatant was then laid on the top of a 15 
- 45% sucrose gradient (in 100mM Na-acetate, 200mM NaCl, pH 5.0) and centrifuged at 
105,000g for 3h at 4°C. Fractions containing EV71 full particles were harvested and sucrose 
in the sample was removed using a spin desalting column (Zeba, Pierce). Virus particles in 
buffer (100mM Na-acetate, 200mM NaCl, pH 5.0) were then concentrated using a 100 KDa 
ultrafiltration tube (Amicon). 
Cryo-EM Sample Preparation 
EV71 particles were incubated with EV71 inhibitor NLD32,33 at 4°C for 24h, with a molar 
UDWLRRI(9SDUWLFOH1/'RI7KHQȝO of SCARB2 (6.5 mg/ml, in 20mM Tris, 
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P01D&OS+ZDVPL[HGZLWKȝORI(9PJPOLQP01D-acetate, 
200mM NaCl, pH 5.0), with a molar ratio of EV71 particle: SCARB2 of 1:100. The pH of 
the mixture was 5.1. Immediately after this, the mixture was applied to a glow-charged 
ultrathin carbon grid (Agar Scientific), blotted by filter paper and vitrified by plunging into 
liquid ethane using a Vitrobot mark IV (FEI). 
Cryo-EM Data Collection 
(OHFWURQGDWDZHUHFROOHFWHGXVLQJD7HFQDL)µ3RODUD¶PLFURVFRSH)(,RSHUDWLQJDW
kV, equipped with a Gatan GIF Quantum energy filter (30 eV energy selecting slit width) and 
a Gatan K2 Summit direct electron detector. Data was recorded as movies (32 frames, each 
0.25 s) in super-resolution mode using SerialEM34 with a defocus range 0.5 - ȝP7KH
calibrated magnification was 37037x, corresponding to a pixel size of 1.35 Å. The dose rate 
was ~4 e-/ A2/ s, resulting in a total electron dose of 35 e-/ A2. 
Cryo-EM Data Processing 
Frames of each movie were aligned and averaged using MotionCorr2 35  and the contrast 
transfer function parameters were determined with CTFFIND336. Micrographs with 
astigmatism or significant drift were discarded. Particles were automatically picked using 
ETHAN37 and then manually screened in EMAN238. The structure was calculated with 
Relion 1.3 following the gold-standard refinement procedure39. Reference-free 2D-class 
averaging was performed for initial model generation. Template-based 3D classification and 
refinement was performed using initial models generated by filtering the crystal structure of 
EV71 (PDB: 3VBH5) to 50 Å resolution. The final density map was calculated using 10443 
particles from 757 micrographs, with an overall resolution of 3.4 Å, estimated by Fourier 
shell correlation39 (Extended Data Fig. 1a).  
Model Building 
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The crystal structure of EV71 (PDB: 3VBH5) and the structure of SCARB2 (PDB: 4Q4B6) 
were fitted into the electric potential map in COOT40. The model was further improved using 
Phenix.real_space_refine41. VP1 residues 11-17 of EV71 were unclear and not built into the 
final model. Refinement statistics are given in Extended Data Table 1. 
The residues forming the EV71-SCARB2 interface were identified with PISA 42. The 
roadmaps were done using Rivem43. Coordinates 3J6N, 6EIT, 3J8F, 3DPR and 3IYP for 
virus-receptor complexes of CV-B3/CAR (Coxsackievirus and adenovirus receptor), CV-
A24/ICAM-1, PV-1/CD155, HRV-2/V3 complex (very-low-density lipoprotein module V3) 
and echovirus-7/DAF (decay-accelerating factor) complex, respectively15,22,44-47 were used 
for preparation of Extended Data Fig. 3. All figures were prepared with PYMOL 47 and 
CHIMERA48. 
Acknowledgments 
D.Z. was supported by China Scholarship Council-University of Oxford Scholarship, J.R. by 
the Wellcome Trust (101122/Z/13/Z), and D.I.S. and E.E.F. by the UK Medical Research 
Council (MR/N00065X/1). This is a contribution from the UK Instruct Centre. The Wellcome 
Trust Centre for Human Genetics is supported by the Wellcome Trust (grant 090532/Z/09/Z).  
Author Contributions  
D.Z.  and A.K performed experiments. D.Z., J.R., and D.I.S. analysed the results and together 
with E.E.F. and Y.Z. wrote the manuscript. All authors read and approved the manuscript. 
 
 
Author Information 
 12 
The structure is available from the PDB, accession code XXX. The electron density map is 
available from EMDB, accession code YYYY. The EM data are available from EMPIAR, 
accession code ZZZZ. Reprints and permissions information is available at 
www.nature.com/reprints. The authors declare competing financial interests: details are 
available in the online version of the paper. Readers are welcome to comment on the online 
version of the paper. Correspondence and requests for materials should be addressed to 
J.R. (ren@strubi.ox.ac.uk) or D.I.S. (dave@strubi.ox.ac.uk). 
 
 
 
 
 
Figure Legends 
Fig. 1 | Phylogeny and the quality of the EV71/SCARB2 EM structure. a, Phylogenetic 
tree of the HFMD causing enteroviruses derived by comparing the capsid sequences. b, 
EV71/SCARB2 complex viewed down the 2-fold icosahedral axis with left half of the 
particle shown as 3D reconstruction coloured by radius from blue through cyan, green and 
yellow to orange from lowest to highest radius, and right half of the complex shown as 
ribbons coloured in blue, green, red and orange for VP1, VP2, VP3 and SCARB2 
respectively. c, d, Electron density maps for the bound pocket-binding inhibitor NLD and 
surrounding residues (c), and for residues at EV71 (green and blue lines) and SCARB2 
(yellow lines) interface (d).     
Fig. 2 | Complex formation of EV71 and SCARB2. a, The position and orientation of the 
bound SCARB2 on an EV71 protomer. EV71 VP1-4 are coloured in blue, green, red and 
yellow, respectively; the pocket-binding inhibitor NLD is shown as magenta spheres; VP1 
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GH and VP2 EF loops that interact directly with the receptor (orange ribbons) are drawn as 
thick coils. b, ĮĮDQGĮKHOLx bundle of the EV71 bound SCARB2 (orange) has similar 
conformation to that of the apo structure at pH 6.5 (red). c, Conformational differences of the 
helix bundle of SCARB2 at pH 6.5 (red) and pH 4.8 (blue). The side chain of the putative pH 
sensor H150 that caps the C-WHUPLQXVRIĮDWS+UHGVticks) becomes the first residue of 
Įat pH 4.8 (blue stick).    
Fig. 3 | Details of EV71 and SCARB2 interactions. a, VP1 GH and VP2 EF loops form a 
platform for SCARB2 binding. The two loops and the receptor are shown as ribbons, and the 
rest of the viral protomer as surface representation. The colour scheme is as in the Fig. 2. b, 
Roadmap showing the foot print (brightly coloured) of SCARB2 on the viral surface. The 
black dots mark the canyon region of a viral protomer. c, Residues at the EV71 and SCARB2 
interface. Side chains of EV71 are shown as cyan sticks, and those of SCARB2 as grey 
sticks. d, e, EV71 and SCARB2 interface with EV71 shown as an electrostatic surface and 
SCARB2 as sticks (d), and vice versa (e).    
Fig. 4 | Epitopes of neutralizing antibodies and mechanism of uncoating. a, Roadmap 
showing the relative positions of the receptor foot print (bright blue and green) and escape 
mutations of neutralising antibodies (yellow). b, Cartoon representation showing the 
mechanism of receptor triggered XQFRDWLQJRI(97KHĮRIWKHERXQG6&$5%DQFKRUV
the receptor on the binding platform consisting of the VP1 GH and VP2 EF loops. As the pH 
drops in the late endosome the pH sensor H150 triggers conformational changes of the helix 
EXQGOHRIĮ ĮDQG ĮRIWKHUHFHSWRUĮPRYHVWRZDUGVDQGGLVWorts the conformation of 
the VP1 GH loop, which in turn triggers the release of the VP1 pocket factor and viral 
particle expansion.    
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